MiniMed Group Inc. Common Stock vs T Rowe Price Group Inc — how do they compare? MiniMed Group Inc. Common Stock trades at $19.55 (market cap $5.38B), while T Rowe Price Group Inc trades at $104.25 (market cap $22.20B). The key difference: T Rowe Price Group Inc is far larger — about 4.1× MiniMed Group Inc. Common Stock's market cap, and T Rowe Price Group Inc pays a 5% dividend while MiniMed Group Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 0 Days and T Rowe Price Group Inc for 115 Days on average.
| MMED | TROW | |
|---|---|---|
Market Cap | $5.38B | $22.20B |
Volume | 9,619,294 | 1,738,431 |
Sector | Health | Financials |
52-Week High | $23.84 | $121.68 |
52-Week Low | $10.80 | $86.19 |
Typical Hold Time | 0 Days | 115 Days |
Enterprise Value | $5.18B | $19.39B |
Dividend Yield | — | 5% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
T. Rowe Price (TROW) trades at $104.23, up 0.61% with bearish technical signals but strong fundamentals including a 29.26% net margin and $2.09B net income. The stock shows consistent earnings beats and dividend growth, supported by $1.90 trillion in assets under management as of August 2026. Recent news highlights dividend sustainability and ETF expansion through acquisitions.
Outlook remains positive with a $112 consensus price target offering 7.5% upside, though technical weakness and market volatility pose near-term risks. The company's 40-year dividend growth history and expanding product portfolio provide stability, while net outflows and competitive pressures require monitoring for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.
Read more on TROW →